183 related articles for article (PubMed ID: 31682981)
61. [Vaccination of the immunocompromised host].
Ullmann AJ; Karthaus M; Cornely OA
Wien Med Wochenschr; 2004 May; 154(9-10):218-25. PubMed ID: 15244047
[TBL] [Abstract][Full Text] [Related]
62. Vaccination and immunization against travel-related diseases in immunocompromised hosts.
Kotton CN
Expert Rev Vaccines; 2008 Jul; 7(5):663-72. PubMed ID: 18564020
[TBL] [Abstract][Full Text] [Related]
63. Early vaccinations are not risk factors for celiac disease.
Myléus A; Stenlund H; Hernell O; Gothefors L; Hammarström ML; Persson LÅ; Ivarsson A
Pediatrics; 2012 Jul; 130(1):e63-70. PubMed ID: 22732174
[TBL] [Abstract][Full Text] [Related]
64. Adherence and immune response to revaccination following hematopoietic stem cell transplantation at a pediatric onco-hematology reference center.
Gouveia-Alves F; Gouveia R; Ginani VC; Seber A; Kuramoto DA; Murad GFA; Spina FG; Petrilli AS; Zecchin VG; Granato C; Carlesse F; de Moraes-Pinto MI
Transpl Infect Dis; 2018 Aug; 20(4):e12903. PubMed ID: 29668078
[TBL] [Abstract][Full Text] [Related]
65. Vaccination Status of Pneumococcal and Other Vaccines in 444 Liver Transplant Patients Compared to a Representative Population Sample.
Weltermann B; Herwig A; Dehnen D; Herzer K
Ann Transplant; 2016 Apr; 21():200-7. PubMed ID: 27052410
[TBL] [Abstract][Full Text] [Related]
66. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine.
Ljungman P; Fridell E; Lönnqvist B; Bolme P; Böttiger M; Gahrton G; Linde A; Ringdén O; Wahren B
J Infect Dis; 1989 Apr; 159(4):610-5. PubMed ID: 2647859
[TBL] [Abstract][Full Text] [Related]
67. Panel Reactive Antibody Responses Against Influenza Vaccination in Kidney Transplant Recipients.
Khishigsuren B; Demir E; Akgul SU; Temurhan S; Ucar AR; Dirim AB; Catikkas NM; Bayraktar A; Caliskan Y; Yazici H; Oguz FS; Turkmen A; Sever MS
Transplant Proc; 2019 May; 51(4):1115-1117. PubMed ID: 31101183
[TBL] [Abstract][Full Text] [Related]
68. Clinical efficacy of seasonal influenza vaccination: characteristics of two outbreaks of influenza A(H1N1) in immunocompromised patients.
Helanterä I; Janes R; Anttila VJ
J Hosp Infect; 2018 Jun; 99(2):169-174. PubMed ID: 29225054
[TBL] [Abstract][Full Text] [Related]
69. [Vaccination needed by over 50-year-old persons].
Plassmann E
MMW Fortschr Med; 2003 Nov; 145(45):26-8. PubMed ID: 14699802
[TBL] [Abstract][Full Text] [Related]
70. Prophylactic antipyretics for prevention of febrile seizures following vaccination.
Monfries N; Goldman RD
Can Fam Physician; 2017 Feb; 63(2):128-130. PubMed ID: 28209678
[No Abstract] [Full Text] [Related]
71. The immunomodulatory effects of measles-mumps-rubella vaccination on persistence of heterologous vaccine responses.
Zimmermann P; Perrett KP; van der Klis FR; Curtis N
Immunol Cell Biol; 2019 Jul; 97(6):577-585. PubMed ID: 30791143
[TBL] [Abstract][Full Text] [Related]
72. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus.
DeStefano F; Mullooly JP; Okoro CA; Chen RT; Marcy SM; Ward JI; Vadheim CM; Black SB; Shinefield HR; Davis RL; Bohlke K;
Pediatrics; 2001 Dec; 108(6):E112. PubMed ID: 11731639
[TBL] [Abstract][Full Text] [Related]
73. Age-appropriate versus up-to-date coverage of routine childhood vaccinations among young children in Israel.
Stein-Zamir C; Israeli A
Hum Vaccin Immunother; 2017 Sep; 13(9):2102-2110. PubMed ID: 28696824
[TBL] [Abstract][Full Text] [Related]
74. Are parental vaccine safety concerns associated with receipt of measles-mumps-rubella, diphtheria and tetanus toxoids with acellular pertussis, or hepatitis B vaccines by children?
Bardenheier B; Yusuf H; Schwartz B; Gust D; Barker L; Rodewald L
Arch Pediatr Adolesc Med; 2004 Jun; 158(6):569-75. PubMed ID: 15184221
[TBL] [Abstract][Full Text] [Related]
75. Measuring the cellular memory B cell response after vaccination in patients after allogeneic stem cell transplantation.
Winkler J; Tittlbach H; Schneider A; Buchstaller C; Mayr A; Vasova I; Roesler W; Mach M; Mackensen A; Winkler TH
Ann Hematol; 2020 Aug; 99(8):1895-1906. PubMed ID: 32519092
[TBL] [Abstract][Full Text] [Related]
76. Vaccination in elite athletes.
Gärtner BC; Meyer T
Sports Med; 2014 Oct; 44(10):1361-76. PubMed ID: 24986118
[TBL] [Abstract][Full Text] [Related]
77. Does the concurrent administration of an inactivated hepatitis A vaccine influence the immune response to other travelers vaccines?
Bock HL; Kruppenbacher JP; Bienzle U; De Clercq NA; Hofmann F; Clemens RL
J Travel Med; 2000; 7(2):74-8. PubMed ID: 10759573
[TBL] [Abstract][Full Text] [Related]
78. Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: A randomized controlled trial.
Mombelli M; Rettby N; Perreau M; Pascual M; Pantaleo G; Manuel O
Vaccine; 2018 Oct; 36(41):6163-6169. PubMed ID: 30181045
[TBL] [Abstract][Full Text] [Related]
79. Today's vaccination policies in Italy: The National Plan for Vaccine Prevention 2017-2019 and the Law 119/2017 on the mandatory vaccinations.
Di Pietro A; Visalli G; Antonuccio GM; Facciolà A
Ann Ig; 2019; 31(2 Supple 1):54-64. PubMed ID: 30994164
[TBL] [Abstract][Full Text] [Related]
80. Compulsory and recommended vaccination in Italy: evaluation of coverage and non-compliance between 1998-2002 in Northern Italy.
Stampi S; Ricci R; Ruffilli I; Zanetti F
BMC Public Health; 2005 Apr; 5():42. PubMed ID: 15845144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
